nmptp treatment decreases the release of dopamine and dopamine accumulates in swollen , distorted axons in the nigrostriatal pathway just above the substantia nigra , followed by severe nerve cell loss in the pars compacta of the substantia nigra and a marked reduction in the dopamine content of the striatum .
C0038590
substantia nigra
C0175412
pars compacta